Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Weight-loss medications are the most commonly excluded category
Given the extensive physiological functions and drug development potential of GLP-1R, targeting GLP-1R has become one of the important approaches in treating obesity
These medications help: Slow stomach emptying, leading to increased feelings of fullness Reduce appetite and food intake by acting on brain centers that control hunger Improve insulin secretion and sensitivity Lower blood sugar levels, especially after meals Promote weight loss through multiple mechanisms Mounjaro (tirzepatide) is actually a dual GIP/GLP-1 receptor agonist, meaning it acts on two hormonal pathways related to blood sugar control and appetite regulation, which may explain its particularly strong effects on weight loss
Recent studies suggest that GLP-1 RAs could improve renal function in patients with chronic kidney disease (CKD) and DM2 (33, 34)
6.1 Carbohydrate needs: timing, type and quantity Performance during endurance and intensive training can be greatly improved by consuming a diet heavy in carbs
